Hengrui Medicine’s Dalpiciclib Hits Superiority Criteria in Phase III Study
China-based Jiangsu Hengrui Medicine Co., Ltd (SHA: 600276) announced that its Phase III SHR6390-III-302 study...
Ascentage Pharma’s H1 2022 Revenue Surges 636.9% on Olverembatinib Sales
China-based Ascentage Pharma (HKG: 6855) reported a significant increase in revenue for the six months...
China-U.S. Listing Agreement Clears Path for Chinese Firms to Stay Listed in the U.S.
China and the United States are nearing an agreement that would allow Chinese firms to...
Shandong Releases Off-Label Drug Use Consensus, Expanding Clinical Guidance
The Shandong Pharmaceutical Association (SPA) has released the “Shandong Province Expert Consensus on Off-label Drug...
ImmuneOnco’s IMM40H Receives NMPA Clinical Trial Approval for CD70 Antibody
ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd announced that it has received clinical trial approval from the...
InnoCare Pharma Files for STAR Market IPO to Raise RMB 4B for Drug R&D
China-based InnoCare Pharma (HKG: 9969) has filed for an initial public offering (IPO) on the...
NMPA Releases 57th Batch of Reference Drugs for Generic Consistency Evaluation
The National Medical Products Administration (NMPA) has released the 57th batch of reference drugs for...
J&J MedTech Joins China’s Surgical Training Program to Skill Up Surgeons
The National Institute of Hospital Administration (NIHA) and the National Health Commission (NHC) launched the...
Sirnaomics’ STP705 Achieves 100% Complete Remission in Basal Cell Carcinoma Study
Sino-US siRNA therapy developer Sirnaomics Ltd (HKG: 2257) announced positive results from a Phase II...
NMPA Reclassifies Omeprazole Tablets from Prescription to OTC Status
The National Medical Products Administration (NMPA) announced that omeprazole enteric-coated tablets have been reclassified from...
Henlius Biotech’s PD-1 Inhibitor Serplulimab Secures NMPA Review for Esophageal Cancer
Shanghai Henlius Biotech Inc. (HKG: 2696) announced that the National Medical Products Administration (NMPA) has...
Acchrom Tech Raises USD 14.45M in Angel Round Led by BioTrack Capital to Expand Chromatography Solutions
Beijing-based chromatography specialist Acchrom Tech has raised RMB 100 million (USD 14.45 million) in an...
JD Healthcare’s H1 2022 Financial Report Shows Strong Growth in Revenue and Profits
JD Healthcare, a unit of China’s e-commerce giant JD.com (NASDAQ: JD), reported robust financial results...
Everest Medicines CEO Resigns as Trodelvy Sale Completed
China-based biotech Everest Medicines (HKG: 1952) announced the resignation of CEO Dr. Kerry Blanchard, effective...
Shanghai Bao Pharma Raises USD 100M in Series B to Advance Drug Delivery Tech
Shanghai Bao Pharmaceuticals Co., Ltd has raised over USD 100 million in a Series B...
Lab Direct Raises USD 10M in Series A+ to Expand Digital Supply Chain Platform
Shanghai-based life science digital supply chain platform Lab Direct has raised USD 10 million in...
Health Plus Receives Strategic Investment from Meinian Onehealth to Drive Healthcare Innovation
Beijing-based Health Plus, a third-party digital managed healthcare service platform, has received strategic investment from...
Prismlab China Raises USD 29.1M in Series C for 3D Printing Expansion
Shanghai-based 3D printing solution provider Prismlab China Ltd has raised RMB 200 million (USD 29.1...
Junshi Biosciences’ TAB009/JS009 and JS110 Advance in Cancer Trials
Junshi Biosciences (HKG: 1877, SHA: 688180) has received approval from the National Medical Products Administration...
Illumina Opens First China Manufacturing Base for Gene Sequencers
US-based Illumina (NASDAQ: ILMN) inaugurated its first manufacturing base in China on August 25, marking...